Jones PW - Search Results

1

The severity of airways obstruction as a determinant of treatment response in COPD.

Calverley P, Pauwels RA, Jones PW, Anderson JA, Vestbos J. Calverley P, et al. Among authors: jones pw. Int J Chron Obstruct Pulmon Dis. 2006;1(3):209-18. doi: 10.2147/copd.2006.1.3.209. Int J Chron Obstruct Pulmon Dis. 2006. PMID: 18046858 Free PMC article.

2

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial.

Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, Maslen TK. Burge PS, et al. Among authors: jones pw. BMJ. 2000 May 13;320(7245):1297-303. doi: 10.1136/bmj.320.7245.1297. BMJ. 2000. PMID: 10807619 Free PMC article. Clinical Trial.

3

Health status deterioration in patients with chronic obstructive pulmonary disease.

Spencer S, Calverley PM, Sherwood Burge P, Jones PW; ISOLDE Study Group. Inhaled Steroids in Obstructive Lung Disease. Spencer S, et al. Among authors: jones pw. Am J Respir Crit Care Med. 2001 Jan;163(1):122-8. doi: 10.1164/ajrccm.163.1.2005009. Am J Respir Crit Care Med. 2001. PMID: 11208636 Clinical Trial.

4

Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations.

Jones PW, Willits LR, Burge PS, Calverley PM; Inhaled Steroids in Obstructive Lung Disease in Europe study investigators. Jones PW, et al. Eur Respir J. 2003 Jan;21(1):68-73. doi: 10.1183/09031936.03.00013303. Eur Respir J. 2003. PMID: 12570111 Free article. Clinical Trial.

5

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial.

Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, Gulsvik A, Anderson J, Maden C; TRial of Inhaled STeroids ANd long-acting beta2 agonists study group. Calverley P, et al. Lancet. 2003 Feb 8;361(9356):449-56. doi: 10.1016/S0140-6736(03)12459-2. Lancet. 2003. PMID: 12583942 Clinical Trial.

6

Prednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE study.

Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA. Burge PS, et al. Among authors: jones pw. Thorax. 2003 Aug;58(8):654-8. doi: 10.1136/thorax.58.8.654. Thorax. 2003. PMID: 12885977 Free PMC article. Clinical Trial.

7

Bronchodilator reversibility testing in chronic obstructive pulmonary disease.

Calverley PM, Burge PS, Spencer S, Anderson JA, Jones PW. Calverley PM, et al. Among authors: jones pw. Thorax. 2003 Aug;58(8):659-64. doi: 10.1136/thorax.58.8.659. Thorax. 2003. PMID: 12885978 Free PMC article.

8

Withdrawal from treatment as an outcome in the ISOLDE study of COPD.

Calverley PM, Spencer S, Willits L, Burge PS, Jones PW; IOSLDE Study Group. Calverley PM, et al. Among authors: jones pw. Chest. 2003 Oct;124(4):1350-6. doi: 10.1378/chest.124.4.1350. Chest. 2003. PMID: 14555565 Clinical Trial.

9

Impact of preventing exacerbations on deterioration of health status in COPD.

Spencer S, Calverley PM, Burge PS, Jones PW. Spencer S, et al. Among authors: jones pw. Eur Respir J. 2004 May;23(5):698-702. doi: 10.1183/09031936.04.00121404. Eur Respir J. 2004. PMID: 15176682 Free article. Clinical Trial.

10

Gender does not influence the response to the combination of salmeterol and fluticasone propionate in COPD.

Vestbo J, Soriano JB, Anderson JA, Calverley P, Pauwels R, Jones P; TRISTAN Study Group. Vestbo J, et al. Respir Med. 2004 Nov;98(11):1045-50. doi: 10.1016/j.rmed.2004.03.017. Respir Med. 2004. PMID: 15526804 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

667 results

Search Page

Filters